Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)
- 作者Mark D. Thornquist; Gilbert S. Omenn; Gary E. Goodman; James E. Grizzle; Linda Rosenstock; Scott Barnhart; Garnet L. Anderson; Samuel Hammar; John Balmes; Martin Cherniack; James Cone; Mark R. Cullen; Andrew Glass; James P. Keogh; Frank Meyskens Jr.; Barbara Valanis; James H. Williams Jr.
- 卷第14卷
- 期第4期
- 印刷ISSN0197-2456
- 文件大小1060.77KB
- 发表时间1993
- DOI10.1016/0197-2456(93)90228-6
- 页码308-324
同作者推荐
Comparing trials for the treatment of myelomatosisJanet A. Dunn; Ian MacLennan · 1992
MRC trial of α2b-interferon maintenance therapy in first plateau phase of multiple myelomaMark T. Drayson; Catherine E. Chapman; Janet A. Dunn; Ade B. Olujohungbe; Ian C. M. MacLennan; for the MRC Working Party on Leukaemia in Adults · 1998
Long-term follow-up of a prospective, double-blind, placebo-controlled randomized trial of clodronate in multiple myelomaEugene V. McCloskey; Janet A. Dunn; John A. Kanis; Ian C. M. MacLennan; Mark T. Drayson; the Medical Research Council Working Party on Leukaemia in Adults · 2001